Prism Medico Standalone December 2019 Net Sales at Rs 9.51 crore, down 19.1% Y-o-Y
January 31, 2020 / 01:02 PM IST
Reported Standalone quarterly numbers for Prism Medico and Pharmacy are:Net Sales at Rs 9.51 crore in December 2019 down 19.1% from Rs. 11.75 crore in December 2018.
Quarterly Net Loss at Rs. 0.09 crore in December 2019 down 131.03% from Rs. 0.29 crore in December 2018.
EBITDA stands negative at Rs. 0.09 crore in December 2019 down 130% from Rs. 0.30 crore in December 2018.
Prism Medico shares closed at 21.25 on January 30, 2020 (BSE) and has given -27.23% returns over the last 6 months and -46.68% over the last 12 months.
| Prism Medico and Pharmacy | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'19 | Sep'19 | Dec'18 | | Net Sales/Income from operations | 9.51 | 6.60 | 11.75 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 9.51 | 6.60 | 11.75 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | -- | | Purchase of Traded Goods | 14.52 | 5.41 | 8.66 | | Increase/Decrease in Stocks | -5.04 | 0.92 | 2.48 | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.09 | 0.05 | 0.09 | | Depreciation | -- | 0.00 | 0.01 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 0.02 | 0.01 | 0.22 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -0.09 | 0.21 | 0.29 | | Other Income | -- | -- | -- | | P/L Before Int., Excpt. Items & Tax | -0.09 | 0.21 | 0.29 | | Interest | -- | 0.00 | 0.00 | | P/L Before Exceptional Items & Tax | -0.09 | 0.21 | 0.29 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -0.09 | 0.21 | 0.29 | | Tax | -- | -0.01 | -- | | P/L After Tax from Ordinary Activities | -0.09 | 0.22 | 0.29 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -0.09 | 0.22 | 0.29 | | Equity Share Capital | 6.06 | 6.06 | 6.06 | | Reserves Excluding Revaluation Reserves | -- | 7.49 | 7.19 | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.15 | 0.37 | 0.48 | | Diluted EPS | -0.15 | 0.37 | 0.48 | | EPS After Extra Ordinary | | Basic EPS | -0.15 | 0.37 | 0.48 | | Diluted EPS | -0.15 | 0.37 | 0.48 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Transport Corporation of India: Good bet with strong execution, focus on technology driving outperformance Watch more 
Bitcoin is at a "tipping point," Citi says Watch more 
Chinese hackers target Indian vaccine makers SII, Bharat Biotech, says security firm Watch more 
Interview | Co-WIN app is scalable, vaccinations can go up to 1 crore a day: RS Sharma Watch more 
